At the Annual General Meeting on 14 November, LiverWELL welcomed three new Directors to our Board. We are very excited to announce that Daphne Sawlwin, Sharon Bates and Paul Gow have joined the LiverWELL Board. Their expertise and contribution will be exceptionally valuable to meeting our strategic goals as we move toward 2024, and on our long term goal of viral hepatitis elimination by 2030.
We convey our sincere thanks to outgoing Board members Phoebe Van Lambaart, Jarrod McMaugh and Kiryu Yap for their contributions.
To learn more about our new directors and their careers, please click the link below to view our Board profiles.